Nuclear Medicine Imaging takes photos based on the chemistry of the human body. Due to the rising prevalence of target illnesses, the technology is seeing a spike in usage.
In the last decade, there has been a major evolution of hybrid systems due to technological breakthroughs in the field of imaging. The use of integrated PET modalities is a significant advancement in this area. The PET/CT modality has been so successful in terms of innovation that major imaging system manufacturers no longer offer solo PET systems. Furthermore, one of the key drivers for the market is the growth in the occurrence of cancer and cardiac diseases. Nuclear medicine has a lot of potential for treating cancer and heart disease. There is substantial evidence that using nuclear imaging techniques to diagnose a tumor has a greater influence on patient management in terms of tumor surveillance and treatment response.
The COVID19 has resulted in a profound re-evaluation of the advantages and costs of cancer care. The pandemic has been a devastating disease worldwide. Although an important number of young healthy people have been affected, elderly, comorbid and immunosuppressed patients have been especially compromised. For instance, the largest report up until September 30, 2020, came from the COVID-19 and Cancer Consortium (CCC19), that reported 30-day all-cause mortality for 928 patients from the United States, Canada, and Spain with laboratory confirmed SARS-CoV-2 and a diagnosis of invasive or hematologic malignancy between March 17, and April 16, 2020. Of those receiving anticancer therapy, only 16% (38 patients) had received immunotherapy, including immune checkpoint blockade (ICB), allogeneic stem cell transplant, or adoptive cell therapy. The COVID-19 pandemic has had a substantial impact on hospital resources around the world. This has mostly been accomplished by drastically lowering in-patient and outpatient treatment for various diseases, as well as instituting infection prevention and control methods.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=6867
Based on therapy, the market is fragmented into monoclonal antibodies, vaccines, checkpoint inhibitors, cell therapies, immune system modulators, adoptive cell transfer, cytokines, and others. The monoclonal antibodies segment dominated the market in 2020 and generated the total revenue of USD 31.79 billion. It is anticipated to maintain its dominance during the forecast period owing to the diverse set of clinically relevant mechanisms of action like directly targeting tumor cells while simultaneously promoting the induction of long-lasting anti-tumor immune responses. However, the bre-ast cancer segment is expected to witness highest CAGR during the forecast period.
The various application wherein cancer Immunotherapy is utilized includes SPECT Imaging Systems, PET Imaging Systems, and Planar Scintigraphy Imaging SystemA. In 2020, SPECT imaging systems segment accounted for a maximum market revenue share of X% and is expected to remain dominant during the analyzed period.
Based on end-user, the market is fragmented into hospitals, imaging centers, academic & research centers, and others. The hospitals segment dominated the market in 2020 and generated the total revenue of USD X billion. It is anticipated to maintain its dominance during the forecast period. Moreover, the segment is also expected to witness highest CAGR during the analyzed period.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=6867
Additionally, the report provides detailed initiatives that are being taken in the field of Nuclear Medicine Imaging. The Nuclear Medicine Imaging Market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD X billion in 2020 owing to the increasing cancer incidence and higher healthcare spending. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of 11.93% during the forecast period.
Siemens Healthineers, GE Healthcare, Philips, Digirad Corporation, Mediso Medical Imaging Systems, Positron Corporation, Cardinal Health Inc., Bracco Imaging SpA, Hitachi Medical Corporation, Canon Medical Systems Corporation are some of the prominent players operating in the global Nuclear Medicine Imaging market. Several M&A’s along with partnerships have been undertaken by these players to develop Nuclear Medicine Imaging.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=6867
Global Nuclear Medicine Imaging Market Segmentation
Market Insight, by Product
Market Insight, by Application
Market Insight, by End-User
Market Insight, by Region
Top Company Profiles
Final Report will add the analysis of the impact of COVID-19 on this industry.”
In the highly import dependent Indian medical devices market, a large number of indigenous manufacturers of syringes & needles have managed to come up. However, it does not mean that imports are low for this market. Imports, as in the case with other medical devices, are quite high but the domestic manufacturers have been able to tap foreign markets through increasing exports. The target base of consumers is growing steadily which is expected to significantly boost sales in the market.
The report provides a snapshot of the syringes & needles market. It begins with the introduction section which mentions the features and uses of syringes & needles along with a brief description of the various phases in their development. The market overview section provides an insight into the market and highlights the market size. Import and export figures for syringes & needles, both in terms of volume and value have been provided in the next section. It also includes the regional break-up of the imports and exports.
An analysis of the drivers explains the factors leading to the growth of the market which include increasing need of insulin doses, increasing demand for vaccines, improving health infrastructure, growing incidence of diseases, changing demographics and health check-up packages. Some of the major challenges to the market are illegal recycling of syringes & needles and problems associated with usage. Government legislation in the market has been discussed in the next section.
The competition section highlights the features of the major players operating in the market. A brief profile of the major domestic and foreign players in the market along with their financials has been included in this section.
For more informative information, please visit us – https://univdatos.com/report/nuclear-medicine-imaging-market/
A section providing strategic recommendations has been given at the end of the report which gives effective solutions to existing and potential players for improving market share and increasing profitability. The Market report answers the following questions:
What is the aim of the report?
What aspects regarding the regional analysis Market are included in this report?
What is the key information extracted from the report?
- Protective Cultures Market is expected to reach the market valuation of US$ 651.8 million by 2027 expanding at a significant CAGR of 22.5% forecast peri
- Glycomics Market was valued at US$ 1 billion in 2020 and is expected to grow at a CAGR of 14% over the forecast period (2021-2027).
- point when you take a gander at famous publicizing designs today, youll see that they have changed almost no throughout the long 4
- We have a large fleet of vehicles that provide FREE removal services all over the region. We have services such as scrap pickups, drop-off locations.